These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atorvastatin--a new lipid-lowering drug. Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394 [No Abstract] [Full Text] [Related]
3. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB; Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study. Kawashiri MA; Nohara A; Tada H; Mori M; Tsuchida M; Katsuda S; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M Clin Pharmacol Ther; 2008 May; 83(5):731-9. PubMed ID: 17957184 [TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426 [TBL] [Abstract][Full Text] [Related]
6. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
7. Liptruzet: a combination of ezetimibe and atorvastatin. Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796 [No Abstract] [Full Text] [Related]
12. Statins: much more than just a lipid-lowering therapy. Raja SG; Dreyfus GD Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease. Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease. Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303 [TBL] [Abstract][Full Text] [Related]
17. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)]. Nissen S MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143 [No Abstract] [Full Text] [Related]
18. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high]. MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732408 [No Abstract] [Full Text] [Related]
19. Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia. Tanaka N; Momiyama Y; Ohmori R; Yonemura A; Ayaori M; Ogura M; Sawada S; Kusuhara M; Nakamura H; Ohsuzu F Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):e129-30. PubMed ID: 16857954 [No Abstract] [Full Text] [Related]